Anna Ozaki
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 13
- Liver Disease Diagnosis and Treatment 11
-
- Diet, Metabolism, and Disease 5
- Co-authors
- Takaomi Kessoku (15 shared papers)Yasushi Honda (14 shared papers)Masato Yoneda (14 shared papers)Takashi Kobayashi (15 shared papers)Atsushi Nakajima (15 shared papers)Satoru Saito (12 shared papers)Yuji Ogawa (12 shared papers)Kento Imajo (12 shared papers)
In The Last Decade
Anna Ozaki
16 papers receiving 299 citations
Peers
Comparison fields: 5 of 53
- Hepatology 104
- Epidemiology 251
- Endocrinology, Diabetes and Metabolism 116
- Gastroenterology 11
- Physiology 37
Countries citing papers authored by Anna Ozaki
This map shows the geographic impact of Anna Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ozaki more than expected).
Fields of papers citing papers by Anna Ozaki
This network shows the impact of papers produced by Anna Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ozaki. The network helps show where Anna Ozaki may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Ozaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 85 | |
| 2 | 2021 | 78 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 24 | |
| 5 | 2021 | 18 | |
| 6 | 2019 | 11 | |
| 7 | 2020 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2020 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2022 | 2 | |
| 16 | [A case report of sarcoid reactions with hepatocellular carcinoma and two early gastric carcinomas]. | 1993 | 2 |
About Anna Ozaki
Anna Ozaki is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Surgery, Hepatology and Oncology, having authored 16 papers that have together received 306 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers), Liver Disease and Transplantation (3 papers), Alcohol Consumption and Health Effects (2 papers), Gastrointestinal motility and disorders (2 papers), Gastroesophageal reflux and treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Hepatology (104 citations), Epidemiology (251 citations), Endocrinology, Diabetes and Metabolism (116 citations), Gastroenterology (11 citations) and Physiology (37 citations). Anna Ozaki has collaborated with scholars based in Japan and Singapore. Frequent co-authors include Takaomi Kessoku, Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Atsushi Nakajima, Satoru Saito, Yuji Ogawa, Kento Imajo, Michihiro Iwaki and Hiroyuki Kirikoshi. Their work appears in journals such as BMJ Open, Clinical Gastroenterology and Hepatology, Journal of Clinical Biochemistry and Nutrition, International Journal of Molecular Sciences and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.